KIORA PHARMACEUTICALS, INC. License Costs (Deprecated 2018-01-31)
KIORA PHARMACEUTICALS, INC. (KPRX) reported License Costs (Deprecated 2018-01-31) of $12.50 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LicenseCosts · last filed 2018-05-11
- KIORA PHARMACEUTICALS, INC. license costs (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. license costs (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $12.50K, a 0.00% change year-over-year.
- KIORA PHARMACEUTICALS, INC. license costs (deprecated 2018-01-31) for the quarter ending 2015-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. license costs (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. license costs (deprecated 2018-01-31) for fiscal 2015 was $12.50K.
| Period end | License Costs (Deprecated 2018-01-31) 0 month | License Costs (Deprecated 2018-01-31) 1 month | License Costs (Deprecated 2018-01-31) 3 month | License Costs (Deprecated 2018-01-31) 6 month | License Costs (Deprecated 2018-01-31) 9 month | License Costs (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $12.50K 10-Q · filed 2016-08-10 | $12.50K derived: sum of 3 quarters · filed 2016-08-10 | $12.50K derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2016-06-17 | $15.00K 10-Q · filed 2018-05-11 | |||||
| 2016-03-31 | $12.50K 10-Q · filed 2016-05-13 | $12.50K derived: sum of 2 quarters · filed 2016-05-13 | $12.50K derived: sum of 3 quarters · filed 2016-05-13 | $12.50K derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $12.50K 10-K · filed 2016-03-30 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $12.50K 10-Q · filed 2015-11-12 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $12.50K 10-Q · filed 2015-08-12 | ||||
| 2015-03-31 | $12.50K 10-Q · filed 2015-05-18 | |||||
| 2013-09-12 | $50.00K 10-Q · filed 2018-05-11 | |||||
| 1999-02-15 | $12.50K 10-Q · filed 2018-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |